Uploaded on Jul 9, 2024
According to the latest research report by IMARC Group, The Philippines connected healthcare market is projected to exhibit a growth rate (CAGR) of 14.70% during 2024-2032. More Info:- https://www.imarcgroup.com/philippines-connected-healthcare-market
Philippines Connected Healthcare Market by Product Type, Distribution Channel, End User 2024-2032
Philippines Connected
Healthcare Market
Research and Forecast
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved
About IMARC Group
In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management
s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry
vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and
t ransform thei r bus inesses.
IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological
developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology
organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls ,
chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods
are at the top of the company’s exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and
markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients
achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure
las t ing resul ts .
A cc o r d i ng t o t h e l a te s t r e p o r t b y IM A R C Gr o u p , t i t l e d " P h i l i p p i n e s C o n n e c t e d
H ea l t h ca r e M a r ke t : I n d u s t r y T r e n d s , S h a r e , S iz e , G r o w t h , O p p o r t u n i t y a n d
F o r e c a s t 2 0 24 - 2 0 32 , " t h e P h i l i p p i n e s c o nn e c t ed h e a l t h c a r e m a r ke t i s p r o j e c te d to
ex h i b i t a g r o w th r a t e ( C A GR ) o f 1 4 . 70 % d u r i n g 2 02 4 - 2 0 32 .
T he g ro w i n g us e o f d i g i t a l h e a l th t ec h n o l o g i e s a s w e l l as t e l em e d i c i ne i s o n e o f t he
Report f a c t o r s r e s p on s i b l e f o r t h e g ro w t h o f t h e P h i l i p p i n e s c on n e c t ed h e a l t hc a r e m a r k e t .
A dd i t i o n a l l y , a s i n t e r n e t p e ne t r a t i o n a n d sm a r t ph o n e us a g e r i se a c r o ss t h e c ou n t r y ,
mo r e h e a l t hc a r e p r o v i d e r s a n d p a t i en t s a r e u t i l i z i n g d i g i t a l p l a t f o r ms f o r m e d i c a l
Highlight and co n s u l t a t i o n s , h e a l t h mo n i t o r i n g , an d t h e m an a g e me n t o f c h r o n i c c o n d i t i o n s .
T he C O V ID - 1 9 p a n de m i c h a s ac c e l e ra t e d t h i s t r e nd , h i g h l i g h t i n g t h e i m p o r t a n c e o f
Description r em o t e h ea l t h c a r e s e r v i ce s i n r e d u c i n g th e s t r a i n on t r a d i t i o na l h e a l t h ca r e s y s t e m s a nd en s u r i n g c o n t i n u ed a c ce s s t o me d i c a l ca r e . Mo r e o ve r , t e l e m e d i c i n e p l a t f o r m s , m o b i l e
he a l t h a p p s , a n d w e a r a b l e h e a l t h d e v i c e s a r e b ec o m i n g i n t e g r a l c o mp o n e n ts o f t he
he a l t h c a re l a n d s c ap e , o f f e r i n g c o n ve n i e n t a nd e f f i c i e n t s o l u t i o ns f o r b o th u rb a n a nd
r u r a l p o pu l a t i o n s .
R eq u e s t f o r a P D F sa m p le o f th i s r ep o r t :
h t t p s : / /w w w . i ma r c g r o u p . co m / p h i l i p p i n e s -c o n n ec t e d - he a l t h c a re - m ar k e t / re q u e s ts a m p l e
Report Description
Phi l ipp ines Connected Hea l thcare Market Trends :
Ano ther s ign i f i can t d r ive r i s t he suppor t and in i t i a t i ves taken by gove rnment au thor i t ies to enhance hea l thcare
in f ras t ruc tu re and p romo te d ig i ta l hea l th . In add i t i on to th i s , t he gove rnment au thor i t i es have been ac t ive ly
work ing to improve hea l thcare access ib i l i t y and qua l i t y t h rough p rograms l i ke the Un ive rsa l Hea l th Ca re Ac t and
inves tments in hea l th in fo rma t ion techno logy . Co l labora t ions be tween the pub l i c and p r i va te sec to rs a re fos te r ing
innova t ion and expand ing the reach o f connec ted hea l thcare se rv i ces .
Fur the rmore , t he g rowing awareness and accep tance o f p reven t i ve hea l thcare among F i l ip inos a re d r i v ing the
demand fo r connec ted hea l th so lu t ions tha t enab le p roac t ive hea l th management . The in teg ra t ion o f e lec t ron ic
hea l th records (EHRs) and da ta ana ly t i cs i s a lso p lay ing a c ruc ia l ro le in improv ing pa t ien t ou tcomes and
opera t iona l e f f i c ienc ies , wh ich is an t ic ipa ted to d r ive the Ph i l i pp ines connec ted hea l thca re marke t ove r the
fo recas ted pe r iod .
View Report TOC, F igures and Tab les :
h t tps : / /www. imarcgroup.com/phi l ipp ines-connected-hea l thcare-market
Type Insights:
• mHealth Services
• mHealth Devices
• E-Prescription
Function Type Insights:
Report • Remote Pat ient Monitoring
• Clinical Monitoring
Segmentation • Telemedicine
• Others
Application Insights:
• Diagnosis and Treatment
• Monitoring Appl icat ion
• Wellness and Prevention
• Healthcare Management
• Others
Regional Insights:
Report • Luzon
• Visayas
Segmentation
• Mindanao
How has the Philippines connected healthcare market
performed so far and how will it perform in the coming
years?
What has been the impact of COVID-19 on the Philippines
connected healthcare market?
What is the breakup of the Philippines connected healthcare
market on the basis of type?
Key
What is the breakup of the Philippines connected healthcare
market on the basis of function type?
Questions
Answered in What is the breakup of the Philippines connected healthcare market on the basis of application?
the Report What are the various stages in the value chain of the
Philippines connected healthcare market?
What are the key driving factors and challenges in the
Philippines connected healthcare?
What is the structure of the Philippines connected healthcare
market and who are the key players?
What is the degree of competition in the Philippines
connected healthcare market?
1 P r e f a c e
2 S c o p e a n d M e t h o d o l o g y
2 . 1 O b j e c t i v e s o f t h e S t u d y
2 . 2 S t a k e h o l d e r s
2 . 3 D a t a S o u r c e s
2 . 3 . 1 P r i m a r y S o u r c e s
2 . 3 . 2 S e c o n d a r y S o u r c e s
2 . 4 M a r k e t E s t i m a t i o n
Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h2 . 4 . 2 T o p - D o w n A p p r o a c h
2 . 5 F o r e c a s t i n g M e t h o d o l o g y
3 E x e c u t i v e S u m m a r y
4 P h i l i p p i n e s C o n n e c t e d H e a l t h c a r e M a r k e t – I n t r o d u c t i o n
Contents 4 . 1 O v e r v i e w4 . 2 M a r k e t D y n a m i c s
4 . 3 I n d u s t r y T r e n d s
4 . 4 C o m p e t i t i v e I n t e l l i g e n c e
5 P h i l i p p i n e s C o n n e c t e d H e a l t h c a r e M a r k e t L a n d s c a p e
5 . 1 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
5 . 2 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 P h i l i p p i n e s C o n n e c t e d H e a l t h c a r e M a r k e t - B r e a k u p b y T y p e
6 . 1 m H e a l t h S e r v i c e s
6 . 1 . 1 O v e r v i e w
6 . 1 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 1 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 1 . 4 M a r k e t B r e a k u p b y F u n c t i o n T y p e
6 . 1 . 5 M a r k e t B r e a k u p b y A p p l i c a t i o n
6 . 2 m H e a l t h D e v i c e s
6 . 2 . 1 O v e r v i e w
6 . 2 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 2 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 2 . 4 M a r k e t B r e a k u p b y F u n c t i o n T y p e
6 . 2 . 5 M a r k e t B r e a k u p b y A p p l i c a t i o n
6 . 3 E - P r e s c r i p t i o n
6 . 3 . 1 O v e r v i e w
6 . 3 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 3 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 3 . 4 M a r k e t B r e a k u p b y F u n c t i o n T y p e
6 . 3 . 5 M a r k e t B r e a k u p b y A p p l i c a t i o n
6 . 4 A t t r a c t i v e I n v e s t m e n t P r o p o s i t i o n b y T y p e
7 P h i l i p p i n e s C o n n e c t e d H e a l t h c a r e M a r k e t - B r e a k u p b y
F u n c t i o n T y p e
Table of 7 . 1 R e m o t e P a t i e n t M o n i t o r i n g
7 . 1 . 1 O v e r v i e w
7 . 1 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
Contents 7 . 1 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )7 . 1 . 4 M a r k e t B r e a k u p b y T y p e
7 . 1 . 5 M a r k e t B r e a k u p b y A p p l i c a t i o n
7 . 2 C l i n i c a l M o n i t o r i n g
7 . 2 . 1 O v e r v i e w
7 . 2 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
7 . 2 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
7 . 2 . 4 M a r k e t B r e a k u p b y T y p e
7 . 2 . 5 M a r k e t B r e a k u p b y A p p l i c a t i o n
7 . 3 T e l e m e d i c i n e
7 . 3 . 1 O v e r v i e w
7 . 3 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
7 . 3 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
7 . 3 . 4 M a r k e t B r e a k u p b y T y p e
7 . 3 . 5 M a r k e t B r e a k u p b y A p p l i c a t i o n
F o r m o r e i n f o r m a t i o n , v i s i t :
h t t p s : / / w w w. im a rcg ro u p . co m / p h i l i p p in e s - c o n n ec t ed - h e a l t h c a re -
m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024 IMARC Al l R ights Reserved
Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f
I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be
rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so
no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing ,
reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress
c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) .
Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion
have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f
pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f
war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC
accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r
i naccu rac ies i f any f ound th is pub l i ca t ion .
IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l
Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re
reg i s te red t rademarks o f t he i r r espec t i ve compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us:
Comments